APA (7th ed.) Citation

LR, R., L, K., PS, M., RK, S., C, P., & R, G. (2025). Management of Relapsed/Refractory Myeloma in Resource Constrained Setting: Median age (years)Age (Years)Immunoglobulin subtypeHb (G/dL)Serum creatinineeGFR mL/minuteSerum albumin (g/dL) Serum LDHPlatelets countsCirculating plasma cells CytogeneticsHypercalcemiaCo-morbiditiesDiabetesHypertensionHypothyroidismF/H of malignancy. Clinical lymphoma, myeloma & leukemia, 25(11), e950. https://doi.org/10.1016/j.clml.2025.07.007

Chicago Style (17th ed.) Citation

LR, Reddy, Kumar L, Malik PS, Sahoo RK, Prasad C, and Gupta R. "Management of Relapsed/Refractory Myeloma in Resource Constrained Setting: Median Age (years)Age (Years)Immunoglobulin SubtypeHb (G/dL)Serum CreatinineeGFR ML/minuteSerum Albumin (g/dL) Serum LDHPlatelets CountsCirculating Plasma Cells CytogeneticsHypercalcemiaCo-morbiditiesDiabetesHypertensionHypothyroidismF/H of Malignancy." Clinical Lymphoma, Myeloma & Leukemia 25, no. 11 (2025): e950. https://doi.org/10.1016/j.clml.2025.07.007.

MLA (9th ed.) Citation

LR, Reddy, et al. "Management of Relapsed/Refractory Myeloma in Resource Constrained Setting: Median Age (years)Age (Years)Immunoglobulin SubtypeHb (G/dL)Serum CreatinineeGFR ML/minuteSerum Albumin (g/dL) Serum LDHPlatelets CountsCirculating Plasma Cells CytogeneticsHypercalcemiaCo-morbiditiesDiabetesHypertensionHypothyroidismF/H of Malignancy." Clinical Lymphoma, Myeloma & Leukemia, vol. 25, no. 11, 2025, p. e950, https://doi.org/10.1016/j.clml.2025.07.007.